1. Home
  2. WBX vs PDSB Comparison

WBX vs PDSB Comparison

Compare WBX & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wallbox N.V.

WBX

Wallbox N.V.

HOLD

Current Price

$2.96

Market Cap

53.4M

ML Signal

HOLD

Logo PDS Biotechnology Corporation

PDSB

PDS Biotechnology Corporation

HOLD

Current Price

$1.07

Market Cap

62.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WBX
PDSB
Founded
2015
2005
Country
Spain
United States
Employees
696
10
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.4M
62.0M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
WBX
PDSB
Price
$2.96
$1.07
Analyst Decision
Buy
Strong Buy
Analyst Count
4
2
Target Price
$4.75
$9.00
AVG Volume (30 Days)
8.7K
1.0M
Earning Date
05-06-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
28.16
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$18.10
N/A
Revenue Next Year
$94.11
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.23
$0.51
52 Week High
$7.83
$1.90

Technical Indicators

Market Signals
Indicator
WBX
PDSB
Relative Strength Index (RSI) 57.72 48.34
Support Level $2.84 $0.91
Resistance Level $3.14 $1.12
Average True Range (ATR) 0.15 0.17
MACD 0.03 -0.03
Stochastic Oscillator 71.19 12.73

Price Performance

Historical Comparison
WBX
PDSB

About WBX Wallbox N.V.

Wallbox NV is a smart electric vehicle charging and energy management company. It creates a smart charging system combining technology design that manages the communication between the user, vehicle, grid, building, and charger. The company designs, manufactures, and distributes faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments: Europe, the Middle East and Asia (EMEA), its key revenue-generating segment, North America, and Asia-Pacific.

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells. The company has determined that it operates as a single reportable segment, developing a growing pipeline of targeted immunotherapies designed to overcome the limitations of current immunotherapy.

Share on Social Networks: